Forecasts data is unavailable for this security.
Consensus recommendation
- 20-Feb-25
- 20-Nov-25
- 18-Dec-25
- 15-Jan-26
- 26-Feb-26
Select bar for recommendation details.
| Recommendations | 26-Feb-26 | |
|---|---|---|
| Buy | 3 | |
| Outperform | 0 | |
| Hold | 1 | |
| Sell | 0 | |
| Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Ascletis Pharma Inc have a median target of 22.84, with a high estimate of 31.95 and a low estimate of 13.74. The median estimate represents a 58.41% increase from the last price of 14.42.
| High | 121.5% | 31.95 |
| Med | 58.4% | 22.84 |
| Low | -4.7% | 13.74 |
Earnings history & estimates in CNY
| Average growth rate | -42.31% |
More ▼
Revenue history & estimates in CNY
| Average growth rate | -0.78% |
More ▼
